Literature DB >> 12778130

Tumorigenesis and the angiogenic switch.

Gabriele Bergers1, Laura E Benjamin.   

Abstract

It has become evident that we cannot understand tumour growth without considering components of the stromal microenvironment, such as the vasculature. At the same time, the tumour phenotype determines the nature of the tumour vasculature. Much research is now devoted to determining the impact of angiogenesis on tumour development and progression, and the reciprocal influences of tumour products on the microvasculature. A more detailed understanding of the complex parameters that govern the interactions between the tumour and vascular compartments will help to improve anti-angiogenic strategies-- not only for cancer treatment, but also for preventing recurrence.

Entities:  

Mesh:

Year:  2003        PMID: 12778130     DOI: 10.1038/nrc1093

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  1039 in total

Review 1.  Lung cancer therapeutics that target signaling pathways: an update.

Authors:  M Roshni Ray; David Jablons; Biao He
Journal:  Expert Rev Respir Med       Date:  2010-10       Impact factor: 3.772

2.  The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer--the ASCOLT study: study protocol for a randomized controlled trial.

Authors:  Raghib Ali; Han-Chong Toh; Whay-Kuang Chia
Journal:  Trials       Date:  2011-12-14       Impact factor: 2.279

3.  Late SV40 factor (LSF) enhances angiogenesis by transcriptionally up-regulating matrix metalloproteinase-9 (MMP-9).

Authors:  Prasanna K Santhekadur; Rachel Gredler; Dong Chen; Ayesha Siddiq; Xue-Ning Shen; Swadesh K Das; Luni Emdad; Paul B Fisher; Devanand Sarkar
Journal:  J Biol Chem       Date:  2011-12-13       Impact factor: 5.157

4.  Proteomic analysis of shear stress-mediated protection from TNF-alpha in endothelial cells.

Authors:  Julie K Freed; Andrew S Greene
Journal:  Microcirculation       Date:  2010-05       Impact factor: 2.628

Review 5.  Metronomic chemotherapy: new rationale for new directions.

Authors:  Eddy Pasquier; Maria Kavallaris; Nicolas André
Journal:  Nat Rev Clin Oncol       Date:  2010-06-08       Impact factor: 66.675

6.  Identification of CD146 expression, angiogenesis, and lymphangiogenesis as progression, metastasis, and poor-prognosis related markers for gallbladder adenocarcinoma.

Authors:  Wenjun Wang; Zhu-lin Yang; Jie-qiong Liu; Song Jiang; Xiong-ying Miao
Journal:  Tumour Biol       Date:  2011-11-12

7.  Differential Effects of EGFL6 on Tumor versus Wound Angiogenesis.

Authors:  Kyunghee Noh; Lingegowda S Mangala; Hee-Dong Han; Ningyan Zhang; Sunila Pradeep; Sherry Y Wu; Shaolin Ma; Edna Mora; Rajesha Rupaimoole; Dahai Jiang; Yunfei Wen; Mian M K Shahzad; Yasmin Lyons; MinSoon Cho; Wei Hu; Archana S Nagaraja; Monika Haemmerle; Celia S L Mak; Xiuhui Chen; Kshipra M Gharpure; Hui Deng; Wei Xiong; Charles V Kingsley; Jinsong Liu; Nicholas Jennings; Michael J Birrer; Richard R Bouchard; Gabriel Lopez-Berestein; Robert L Coleman; Zhiqiang An; Anil K Sood
Journal:  Cell Rep       Date:  2017-12-05       Impact factor: 9.423

8.  Accumulation of nano-sized particles in a murine model of angiogenesis.

Authors:  Thomas R Wittenborn; Esben K U Larsen; Thomas Nielsen; Louise M Rydtoft; Line Hansen; Jens V Nygaard; Thomas Vorup-Jensen; Jørgen Kjems; Michael R Horsman; Niels Chr Nielsen
Journal:  Biochem Biophys Res Commun       Date:  2013-12-07       Impact factor: 3.575

9.  The chemokine receptor CXCR7 is a critical regulator for the tumorigenesis and development of papillary thyroid carcinoma by inducing angiogenesis in vitro and in vivo.

Authors:  Hengwei Zhang; Lei Yang; Xuyong Teng; Zhangyi Liu; Chenxi Liu; Lei Zhang; Zhen Liu
Journal:  Tumour Biol       Date:  2015-09-17

10.  Effect of vascular haemoglobin concentrations on ultrasound-guided diffuse optical tomography in differentiating benign from malignant breast lesions.

Authors:  Ning Lv; Ni He; Yaopan Wu; Chuanmiao Xie; Yue Wang; Yanan Kong; Weidong Wei; Peihong Wu
Journal:  Eur Radiol       Date:  2014-08-06       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.